Latest & greatest articles for cerebral palsy

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on cerebral palsy or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on cerebral palsy and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for cerebral palsy

141. Electrical stimulation in cerebral palsy: a review of effects on strength and motor function

Electrical stimulation in cerebral palsy: a review of effects on strength and motor function Electrical stimulation in cerebral palsy: a review of effects on strength and motor function Electrical stimulation in cerebral palsy: a review of effects on strength and motor function Kerr C, McDowell B, McDonough S CRD summary This review evaluated the efficacy of electrical stimulation in children with cerebral palsy. The authors concluded that the evidence is insufficient to provide conclusive (...) evidence for or against the use of neuromuscular electrical stimulation or threshold electrical stimulation. Despite limitations in the review methodology, the authors' conclusion is likely to reflect the evidence available in this field. Authors' objectives To assess the efficacy of electrical stimulation in strengthening or improving the motor function of children with cerebral palsy (CP). Searching MEDLINE (1966 to 2003), CINAHL (1982 to 2003), AMED (1985 to 2003) and PEDro (1966 to 2003) were

DARE.2004

142. Costs and consequences of botulinum toxin type A use: management of children with cerebral palsy in Germany

Costs and consequences of botulinum toxin type A use: management of children with cerebral palsy in Germany Costs and consequences of botulinum toxin type A use: management of children with cerebral palsy in Germany Costs and consequences of botulinum toxin type A use: management of children with cerebral palsy in Germany Ruiz F J, Guest J F, Lehmann A, Davie A M, Guttler K, Schluter O, Dreiss G Record Status This is a critical abstract of an economic evaluation that meets the criteria (...) for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The use of botulinum toxin injections for the treatment of children with cerebral palsy was compared with no such injections. No further details of the medical treatment were provided. Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Study population

NHS Economic Evaluation Database.2004

143. Speech and language therapy to improve the communication skills of children with cerebral palsy.

Speech and language therapy to improve the communication skills of children with cerebral palsy. BACKGROUND: The production of speech, language and gesture for communication is often affected by cerebral palsy. Communication difficulties associated with cerebral palsy can be multifactorial, arising from motor, intellectual and / or sensory impairments, and children with this diagnosis can experience mild to severe difficulties in expressing themselves. They are often referred to speech (...) and language therapy (SLT) services, to maximise their communication skills and help them to take an independent a role as possible in interaction. This can include introducing augmentative and alternative communication (AAC) systems, such as symbol charts or speech synthesizers, as well treating children's natural forms of communication. Various strategies have been used to treat the communication disorders associated with cerebral palsy but evidence of their effectiveness is limited. OBJECTIVES

Cochrane2004

144. Gastrostomy feeding versus oral feeding alone for children with cerebral palsy.

Gastrostomy feeding versus oral feeding alone for children with cerebral palsy. BACKGROUND: Children with cerebral palsy (CP) can be significantly disabled in terms of their ability to suck, chew and swallow. This can lead to significant impairment in feeding ability and, eventually, to under-nutrition. It can also result in aspiration of food into the lungs. Feeding time may be considerably increased and, instead of being an enjoyable experience, mealtimes may be distressing for both the child (...) facilitate feeding of children with CP, many carers find it very difficult to accept this intervention emotionally. The treatment is also relatively costly. For all of these reasons, its effectiveness requires assessment. OBJECTIVES: To assess the effects of nutritional supplementation given via gastrostomy or jejunostomy in children with feeding difficulties due to cerebral palsy. SEARCH STRATEGY: We searched the Cochrane Library's register of controlled trials (CENTRAL) up to Issue 4, 2003, MEDLINE

Cochrane2004

145. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy. BACKGROUND: Cerebral palsy (CP) is a central nervous system deficit resulting from a non-progressive lesion in the developing brain. Although the brain lesions are static, the movement disorders that arise are not unchanging and are characterised by atypical muscle tone, posture and movement (Rang 1990). The spastic motor type is the most common form of CP and its (...) as an adjunct to managing the upper limb in children with spastic cerebral palsy. Only one of the two identified RCTs reported some promising results in support of reduced muscle tone following BtA injections. Further research incorporating larger sample sizes, rigorous methodology, measurement of upper limb function and functional outcomes is essential.

Cochrane2004

146. Chorioamnionitis and cerebral palsy in term and near-term infants.

Chorioamnionitis and cerebral palsy in term and near-term infants. CONTEXT: Half of all cases of cerebral palsy (CP) occur in term infants, for whom risk factors have not been clearly defined. Recent studies suggest a possible role of chorioamnionitis. OBJECTIVE: To determine whether clinical chorioamnionitis increases the risk of CP in term and near-term infants. DESIGN, SETTING, AND PATIENTS: Case-control study nested within a cohort of 231 582 singleton infants born at 36 or more weeks

JAMA2003

147. Cerebral palsy and intrauterine growth in single births: European collaborative study.

Cerebral palsy and intrauterine growth in single births: European collaborative study. BACKGROUND: Cerebral palsy seems to be more common in term babies whose birthweight is low for their gestational age at delivery, but past analyses have been hampered by small datasets and Z-score calculation methods. METHODS: We compared data from ten European registers for 4503 singleton children with cerebral palsy born between 1976 and 1990 with the number of births in each study population. Weight (...) and gestation of these children were compared with reference standards for the normal spread of gestation and weight-for-gestational age at birth. FINDINGS: Babies of 32-42 weeks' gestation with a birthweight for gestational age below the 10th percentile (using fetal growth standards) were 4-6 times more likely to have cerebral palsy than were children in a reference band between the 25th and 75th percentiles. In children with a weight above the 97th percentile, the increased risk was smaller (from 1.6

Lancet2003

148. Effects of conductive education intervention for children with a diagnosis of cerebral palsy: an AACPDM evidence report

Effects of conductive education intervention for children with a diagnosis of cerebral palsy: an AACPDM evidence report Effects of conductive education intervention for children with a diagnosis of cerebral palsy: an AACPDM evidence report Effects of conductive education intervention for children with a diagnosis of cerebral palsy: an AACPDM evidence report Darrah J, Watkins B, Chen L, Bonin C CRD summary This review addressed the effects of conductive education in children with cerebral palsy (...) . The authors concluded that the quality of evidence was insufficient to determine whether conductive education is effective or not. Despite attempts to capture all study types, restricting studies to those published in English may have had a significant impact on the review's findings. The authors' conclusions are appropriately cautious. Authors' objectives To review the effects of conductive education (CE) in children diagnosed with cerebral palsy (CP). Searching The following electronic databases were

DARE.2003

149. Effects of surgical adductor releases for hip subluxation in cerebral palsy: an AACPDM evidence report

Effects of surgical adductor releases for hip subluxation in cerebral palsy: an AACPDM evidence report Effects of surgical adductor releases for hip subluxation in cerebral palsy: an AACPDM evidence report Effects of surgical adductor releases for hip subluxation in cerebral palsy: an AACPDM evidence report Stott N S, Piedrahita L CRD summary This review evaluated the effects of surgical adductor release for hip subluxation in people with cerebral palsy. The authors concluded that young (...) children with mild hip subluxation may benefit from adductor release; however, this result may reflect a more favourable natural history of this group. Considering the paucity of the evidence reviewed and the lack of methodological detail reported, the conservative conclusions seem appropriate. Authors' objectives To determine the effects of surgical adductor release for hip subluxation in people with cerebral palsy. Searching MEDLINE (1966 to 2003), HealthSTAR (1975 to 2001), CINAHL (1982 to 2002

DARE.2003

150. Hyperbaric oxygen therapy for brain injury, cerebral palsy, and stroke

Hyperbaric oxygen therapy for brain injury, cerebral palsy, and stroke Hyperbaric oxygen therapy for brain injury, cerebral palsy, and stroke Hyperbaric oxygen therapy for brain injury, cerebral palsy, and stroke McDonagh M, Carson S, Ash J S, Russman B S, Stavri P Z, Krage K P, Helfand M CRD summary This review aimed to assess the benefits and harms of hyperbaric oxygen therapy (HBOT) for brain injury, cerebral palsy and stroke. The authors concluded that there was inadequate evidence (...) on the benefits and harms of HBOT for brain injury, cerebral palsy and stroke. This was a well-conducted review and the authors' conclusions are appropriate given the conflicting evidence reviewed. Authors' objectives To assess the benefits and harms of hyperbaric oxygen therapy (HBOT) for brain injury, cerebral palsy and stroke. Searching MEDLINE, Pre-MEDLINE, EMBASE, CINAHL, The Cochrane Library, Health Technology Assessment Database, HealthSTAR, AltHealthWatch and MANTIS were searched from inception

DARE.2003

151. Hyperbaric oxygen therapy for brain injury, cerebral palsy, and stroke

Hyperbaric oxygen therapy for brain injury, cerebral palsy, and stroke Hyperbaric oxygen therapy for brain injury, cerebral palsy, and stroke Hyperbaric oxygen therapy for brain injury, cerebral palsy, and stroke McDonagh M, Carson S, Ash J Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation McDonagh M, Carson S, Ash J. Hyperbaric oxygen (...) therapy for brain injury, cerebral palsy, and stroke. Rockville: Agency for Healthcare Research and Quality (AHRQ). Evidence Report/Technology Assessment No. 85. 2003 Authors' objectives The purpose of this report is to describe the methods, results, and conclusions of a literature review of the benefits and harms of hyperbaric oxygen therapy (HBOT) for brain injury, cerebral palsy, and stroke. Authors' conclusions Evidence from well-conducted clinical studies is limited. The balance of benefits

Health Technology Assessment (HTA) Database.2003

152. Prognosis for gross motor function in cerebral palsy: creation of motor development curves.

Prognosis for gross motor function in cerebral palsy: creation of motor development curves. CONTEXT: Lack of a valid classification of severity of cerebral palsy and the absence of longitudinal data on which to base an opinion have made it difficult to consider prognostic issues accurately. OBJECTIVE: To describe patterns of gross motor development of children with cerebral palsy by severity, using longitudinal observations, as a basis for prognostic counseling with parents and for planning (...) clinical management. DESIGN: Longitudinal cohort study of children with cerebral palsy, stratified by age and severity of motor function and observed serially for up to 4 years during the period from 1996 to 2001. SETTING: Nineteen publicly funded regional children's ambulatory rehabilitation programs in Ontario. PARTICIPANTS: A total of 657 children aged 1 to 13 years at study onset, representing the full spectrum of clinical severity of motor impairment in children with cerebral palsy. MAIN OUTCOME

JAMA2002

153. A review of the efficacy of lower-limb orthoses used for cerebral palsy

A review of the efficacy of lower-limb orthoses used for cerebral palsy A review of the efficacy of lower-limb orthoses used for cerebral palsy A review of the efficacy of lower-limb orthoses used for cerebral palsy Morris C Authors' objectives To assess the efficacy of lower limb orthoses used for children with cerebral palsy (CP). Searching The Cochrane Library (Issue 3, 2000), RECAL Information Services, MEDLINE, CINAHL, EMBASE, SIGLE, AMED and Inspec were searched from 1994 to 2000 (...) sample sizes and may not be reliable. The authors' conclusions about the need for further research were supported by the evidence presented. Implications of the review for practice and research Practice: The author did not state any implications for practice. Research: The author stated that strong evidence is only likely to come from RCTs that ensure baseline similarity between the treatment groups using the diagnostic classification produced by the Surveillance of Cerebral Palsy in Europe

DARE.2002

154. A systematic review of the effectiveness of strength-training programs for people with cerebral palsy

A systematic review of the effectiveness of strength-training programs for people with cerebral palsy A systematic review of the effectiveness of strength-training programs for people with cerebral palsy A systematic review of the effectiveness of strength-training programs for people with cerebral palsy Dodd K J, Taylor N F, Damiano D L Authors' objectives To determine whether strength training is beneficial for people with cerebral palsy (CP). Searching MEDLINE (via PubMed), EMBASE, CINAHL (...) , SPORTDiscus, DARE, PsycINFO, ERIC, AusportMed, AMI, the Cochrane Library and PEDro were searched from their inception to 2000, using the keywords 'cerebral palsy' in combination with 'exercise', 'strength' and 'physical training'. The search was limited to publications in the English language. In addition, the reference lists of identified articles were examined and the related articles link on PubMed was used to identify further relevant articles. Study selection Study designs of evaluations included

DARE.2002

155. Gait analysis for pediatric cerebral palsy

Gait analysis for pediatric cerebral palsy Gait analysis for pediatric cerebral palsy Gait analysis for pediatric cerebral palsy BlueCross BlueShield Association Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. The BlueCross BlueShield Association Technology Evaluation Center website ( ) includes the most recent 3 years of TEC Assessments. To request older reports, please (...) use the “contact us” feature on the website. Citation BlueCross BlueShield Association. Gait analysis for pediatric cerebral palsy. Chicago: BlueCross BlueShield Association (BCBS). TEC Assessment 16(19). 2002 Authors' objectives This Assessment will review the available evidence to determine if, when compared with traditional clinical assessment of gait, use of gait analysis results in better outcomes of therapies to improve walking in children who have cerebral palsy. Project page URL Indexing

Health Technology Assessment (HTA) Database.2002

156. What is the effectiveness of Botulinum Toxin A in the reduction of upper limb spasticity in children with cerebral palsy?

What is the effectiveness of Botulinum Toxin A in the reduction of upper limb spasticity in children with cerebral palsy? What is the effectiveness of Botulinum Toxin A in the reduction of upper limb spasticity in children with cerebral palsy? What is the effectiveness of Botulinum Toxin A in the reduction of upper limb spasticity in children with cerebral palsy? Hender K Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality (...) of this assessment has been made for the HTA database. Citation Hender K. What is the effectiveness of Botulinum Toxin A in the reduction of upper limb spasticity in children with cerebral palsy? Clayton, Victoria: Centre for Clinical Effectiveness (CCE) 2001: 11 Authors' objectives This aim of this critical appraisal was to assess the effectiveness of Botulinum Toxin A in the reduction of upper limb spasticity in children with cerebral palsy. Project page URL Indexing Status Subject indexing assigned by CRD

Health Technology Assessment (HTA) Database.2001

157. The efficacy of botulinum toxin A in the treatment of spasticity in ambulant children with cerebral palsy: a structured review

The efficacy of botulinum toxin A in the treatment of spasticity in ambulant children with cerebral palsy: a structured review The efficacy of botulinum toxin A in the treatment of spasticity in ambulant children with cerebral palsy: a structured review The efficacy of botulinum toxin A in the treatment of spasticity in ambulant children with cerebral palsy: a structured review Mulligan H, Borkin H, Chaplin K, Croft N, Scherp A Authors' objectives To investigate the efficacy of Botulinum toxin (...) A (BtA) in the treatment of spasticity for the functional outcome of ambulation in children with cerebral palsy. Searching MEDLINE, EMBASE, AMED, EMB Reviews, CINAHL and PEDro were searched using the terms 'Botulinum toxin A' and 'cerebral palsy'. Limitations on the search included articles that were available in New Zealand and those that were written in English. Study selection Study designs of evaluations included in the review Randomised controlled trials (RCTs) or self-controlled experimental

DARE.2001

158. Management of upper limb dysfunction in children with cerebral palsy: a systematic review

Management of upper limb dysfunction in children with cerebral palsy: a systematic review Management of upper limb dysfunction in children with cerebral palsy: a systematic review Management of upper limb dysfunction in children with cerebral palsy: a systematic review Boyd R N, Morris M E, Graham H K Authors' objectives To evaluate the efficacy of different treatments for the management of upper limb dysfunction in children with cerebral palsy (CP). Searching The following databases were (...) searched: MEDLINE from 1966 to December 2000; CINAHL from 1982 to December 2000; ClinPSYC from 1989 to December 2000; DARE (September 2000); PEDro; EBM Reviews: Best Evidence from 1991 to December 2000; the Cochrane Database of Systematic Reviews (Issue 4, 2000); and the Cochrane Controlled Trials Register (CENTRAL/CCTR). The exploded search terms used were 'cerebral palsy', 'upper limb', 'spasticity', 'physical therapy or physiotherapy', 'occupational therapy', 'neurodevelopmental therapy

DARE.2001

159. Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review

Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review Boyd R N, Hays R M Authors' objectives To review systematically the current available evidence for botulinum toxin type (...) A (BTX-A) in cerebral palsy management, compared with other options for the lower limb and general body involvement in children. Searching The following sources were searched in December 2000: MEDLINE from 1966; CINAHL (via OVID) from 1982; ClinPSYC from 1989; DARE, PEDro; EBM Reviews: Best Evidence from 1991; the Cochrane Database of Systematic Reviews (Issue 4, 2000); and the Cochrane Controlled Trials Register (CENTRAL/CCTR). The exploded terms used were 'cerebral palsy', 'Botulinum toxin

DARE.2001

160. Botulinum toxin type A in the management of equinus in children with cerebral palsy: an evidence-based economic evaluation

Botulinum toxin type A in the management of equinus in children with cerebral palsy: an evidence-based economic evaluation Botulinum toxin type A in the management of equinus in children with cerebral palsy: an evidence-based economic evaluation Botulinum toxin type A in the management of equinus in children with cerebral palsy: an evidence-based economic evaluation Houltram J, Noble I, Boyd R N, Corry I, Flett P, Graham H K Record Status This is a critical abstract of an economic evaluation (...) that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Two treatments for the conservative (non-surgical) management of equinus due to calf spasticity, in children with cerebral palsy, were examined. The treatments were intramuscular injection of botulinum toxin type A (BTX-A) and serial casting (SC). The dose

NHS Economic Evaluation Database.2001